Higher expression of COL1A1, COL1A2, COL3A1, COL4A1, COL4A2, and COL5A2 was negatively correlated with the prognosis of glioma patients (Yin et al. 2021). The gene discussed is COL4A2; the disease is central nervous system cancer.